KRAS and neoplasm: Interestingly, Iskandar et al.136 observed that hyperactivation of mutant KRAS with the small molecule C1 leads to the activation of the PI3K–AKT pathway, which enhances ROS generation (see below), leading to mitochondrial dysfunction, cell death and blockade of tumours with mutant KRAS.